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Left ventricular dyssynchrony assessment by
phase analysis from gated PET-FDG scans
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Jelena-Rima Ghadri, MD,a Bernhard A. Herzog, MD,a Lars Husmann, MD,a
Mathias Wolfrum, MD,a Silke M. Ku¨est, MD,a Michael Fiechter, MD,a,b
Oliver Gaemperli, MD,a and Philipp A. Kaufmann, MDa,b
Background. The outcome of patients with severe ischaemic left ventricular (LV) dys-
function is determined by the extent of myocardial viability and the presence of LV
dyssynchrony. We aimed at assessing both parameters from the same imaging method, i.e.
gated positron emission tomography (PET) F18-fluorodeoxyglucose (FDG) scans.
Methods. Phase analysis from Emory Cardiac Toolbox was applied on gated PET-FDG
scans to assess histogram bandwidth and standard deviation (SD) as a measure of LV dys-
synchrony in 30 heart failure patients (mean ejection fraction: 30.2% ± 13.8%) referred for the
evaluation of myocardial viability. Cut-off values from single-photon emission computed
tomography myocardial perfusion imaging (SPECT-MPI) best predicting cardiac resynchro-
nization therapy (CRT) response served as standard of reference (bandwidth < 135; phase
SD < 43). Severe LV dyssynchrony was diagnosed if both SPECT-MPI values were above these
limits. Intraclass correlation and clinical agreement in detection of severe LV dyssynchrony by
PET vs SPECT were assessed.
Results. There was a significant correlation between PET-FDG and SPECT-MPI for
bandwidth (r 5 0.88, P < .001) and phase SD (r 5 0.88, P < .001) resulting in an excellent
clinical agreement between the two methods of 93%.
Conclusions. Accurate LV dyssynchrony assessment by phase analysis of gated PET-FDG
scans is feasible, allowing assessing myocardial viability and severe LV dyssynchrony in one
scan. (J Nucl Cardiol 2011;18:920–5.)
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INTRODUCTION
Coronary artery disease (CAD) is one of the leading
causes of morbidity and mortality in western countries.
Patients with extensive coronary artery disease (CAD)
are at higher risk to develop heart failure and left ven-
tricular (LV) dysfunction.
In patients with severe ischaemic LV dysfunction
revascularization of viable segments guided by myo-
cardial PET-FDG findings has been shown to improve
outcome.1-4 Recently, it has been shown that not only
myocardial viability but also severe LV dyssynchrony is
an independent predictor of perioperative outcome.5,6
Therefore, it has been advocated that the assessment of
myocardial viability and LV dyssynchrony should be a
routine part of the preoperative evaluation of these
patients.5
Moreover, studies showed that the presence of LV
dyssynchrony as well as the extent of scar tissue and
viable myocardium is directly related to the response to
cardiac resynchronization therapy (CRT). Therefore, it
has been stated that the evaluation for viability and LV
dyssynchrony should be considered in the selection
process for CRT.7-10
For the accurate assessment of LV dyssynchrony,
different imaging methods, such as tissue Doppler
imaging, multigated blood pool ventriculography
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acquisition (MUGA) and magnetic resonance imaging
(MRI) have been developed. For long time, MUGA has
been seen as the most accurate and reproducible non-
invasive technique.11 Lately, phase analysis based on
Fourier harmonic function on gated single-photon-
emission computed tomography myocardial perfusion
imaging (SPECT-MPI) has been suggested as a suitable
option for LV dyssynchrony assessment.12,13
As PET-FDG is considered the most specific tool
for evaluation of viable tissue in ischaemic LV dys-
function where LV dyssynchrony has emerged as
independent predictor of outcome, the assessment of the
latter by gated PET-FDG appears pertinent. Thus, the
aim of this study was to validate the assessment of LV
dyssynchrony from phase analysis from gated PET-FDG
scans vs previously established phase analysis from
gated SPECT-MPI as standard of reference.12,13
MATERIALS AND METHODS
This study includes 30 consecutive patients with
known CAD who were referred for evaluation of viable
myocardium by SPECT-MPI/PET-FDG because of
severe ischaemic LV dysfunction. Patients were inclu-
ded if they had signed informed consent authorizing
their records to be included in our research registry.
SPECT-MPI Image Acquisition and
Interpretation
The SPECT-MPI acquisition was performed
approximately 1 hour after injection of 900 MBq 99mTc-
tetrofosmin at rest on a Ventri dual-head camera (Ventri,
GE Healthcare) with a low-energy, high-resolution col-
limator, a 20% symmetric window at 140 keV, a
64 9 64 matrix, and an elliptic orbit with step-and-shoot
acquisition at 3 intervals over 180 arc (45 right
anterior oblique to 45 left posterior oblique) with 30
steps (60 views). Scan time was set to 25 seconds per
frame for stress and rest, resulting in a total acquisition
time of 14 minutes 52 seconds (including inter-step
rotation time) for each scan as recommended by the
American Society of Nuclear Cardiology (ASNC).14
Images were reconstructed on a dedicated workstation
using a standard iterative reconstruction algorithm with
Ordered Subset Expectation Maximization (OSEM)
with 2 iterations and 10 subsets. Standard short as well
as vertical, and horizontal long axis, and polar maps of
perfusion encompassing the entire left ventricle were
analysed using QGS/QPS software. Effective radiation
dose for the SPECT-MPI study was calculated as 99mTc-
tetrofosmin activity times 7.9 mSv/GBq.
PET-FDG Image Acquisition and
Interpretation
Myocardial viability scans were acquired on a PET/
CT scanner using 250 MBq of FDG. All patients were
advised to fast for at least 6 hours before PET exami-
nation and received a standardized oral glucose load.15
After FDG injection, patients rested for 1 hour before
image acquisition. Images were acquired on a Discovery
(LS/RX) PET/CT scanner (GE Healthcare). CT attenu-
ation maps were used for AC as previously reported.16
Acquired images were reconstructed using attenuation
weighted-OSEM iterative reconstruction (2 iterations
and 8 subsets). FDG uptake polar maps were equally
derived using the Cedars QPS/QGS software package as
for SPECT-MPI. Effective radiation dose for PET-FDG
study was calculated as FDG activity times 0.019 mSv/
MBq.
Assessment of LV Dyssynchrony by SPECT-
MPI and PET-FDG
The Emory Cardiac Toolbox software (Emory
University/Syntermed, Atlanta, GA) for phase analysis
and assessment of LV dyssynchrony from SPECT-MPI
has been extensively validated.12,13,17 The software was
applied on both, gated PET-FDG and SPECT-MPI scans
to assess phase histogram bandwidth and standard
deviation (SD), which are the two parameters best
allowing determination of presence vs absence of LV
dyssynchrony. The previously established optimal cut-
off value for the prediction of response to CRT, i.e. 135
for histogram bandwidth and 43 for phase SD,17 were
used in this study. Severe LV dyssynchrony was con-
sidered to be present if both the parameters were above
the cut-off value. All images were analysed by a reader
who was blinded to the history of the patient.
Statistical Analysis
All statistical analyses were performed using SPSS
software (SPSS 15.0, Chicago, IL, USA). Quantitative
variables were expressed as mean ± standard deviation,
and categorical variables were expressed as frequencies
and percentages. Means of histogram bandwidth and
phase SD assessed by the two different imaging methods
PET-FDG vs SPECT-MPI were compared using Wil-
coxon signed-rank test. Intraclass correlation of the two
parameters, histogram bandwidth and phase SD, from
PET-FDG vs SPECT-MPI was performed. In addition,
clinical agreement and Bland-Altman (BA) limits of
agreement were calculated. A P value of \.05 was
considered to indicate statistical significance.
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RESULTS
In all 30 patients phase analysis of Emory Cardiac
Toolbox was applied successfully using rest MPI scans
and PET-FDG scans, respectively. Baseline character-
istics of the entire study population are given in Table 1.
The SPECT and FDG exams were performed in a time
range between December 2007 and January 2010. The
mean injected activity was 925 ± 12 MBq for the
rest 99mTc-Tetrofosmin SPECT-MPI study and 252 ±
20 MBq for the PET-FDG study resulting in a total
radiation dose of 7.3 ± 1.0 mSv for the SPECT-
MPI scan and 4.8 ± 0.4 mSv for the FDG exam,
respectively.
SPECT-MPI revealed a perfusion defect in 27
patients. Of these, 19 patients had at least partially
preserved FDG uptake, indicating dysfunctional but
viable tissue.
Mean histogram bandwidth by SPECT-MPI and
PET-FDG was 168.7 ± 78.4 and 168.0 ± 66.7 (P =
n.s.), respectively. Mean phase SD by SPECT-MPI
and PET-FDG was 52.7 ± 23.2 and 57.3 ± 27.0
(P = n.s.).
SPECT-MPI identified severe LV dyssynchrony in
18 patients with a mean histogram bandwidth of
225.2 ± 36.7 and a mean phase SD of 68.7 ± 11.3.
Normal LV synchronicity or mild LV dyssynchrony was
found in 12 patients with a mean bandwidth of
83.9 ± 32.8 and a phase SD of 28.7 ± 13.1. In 13 of
these 18 patients there was a flow-metabolism mismatch,
i.e. a perfusion defect in SPECT but preserved FDG
uptake in PET in at least one segment. PET-FDG scans
revealed severe LV dyssynchrony in 20 patients among
which the 18 patients identified by SPECT-MPI. Mean
histogram bandwidth was 204.9 ± 44.1 and mean phase
SD was 68.7 ± 17.0. Mean values of normal or
mild findings by PET-FDG were 94.2 ± 34.0 and
34.5 ± 15.1 for histogram bandwidth and SD, respec-
tively. An example of dyssynchrony assessment from
SPECT-MPI vs PET-FDG is illustrated in Figure 1.
There was a significant correlation between SPECT-
MPI data and PET-FDG scans for histogram bandwidth
(r = 0.88, P \ .001) and phase SD (r = 0.88, P \
.001) (Figure 2). Sensitivity, specificity, PPV and NPV
on a per-patient base were 100%, 83%, 90% and 100%
for data sets from PET-FDG compared to SPECT-MPI
as standard of reference. This resulted in an agreement
of the two methods of 93%.
DISCUSSION
This study investigates the use of PET-FDG scans
to assess severe LV dyssynchrony in patients with
ischaemic LV dysfunction referred for preoperative
evaluation prior to CABG surgery. Our results reveal
that LV dyssynchrony assessment from PET-FDG scans
is feasible and accurate. This allows using the same
scans performed for viability assessment also for
assessment of LV dyssynchrony, which has recently
shown to be an independent predictor of perioperative
outcome in CABG surgery of patients with severe
ischaemic LV dysfunction.
There are several therapeutic strategies, which have
been considered for the treatment of patients with
ischaemic heart failure. As the value of medical therapy
Table 1. Baseline characteristics of study pop-
ulation (n = 30)
Male 22 (73.3%)
Age (years)
Mean ± SD (range) 64 ± 14 (35–83)
Body mass index (kg/m2)
Mean ± SD (range) 25.8 ± 3.7 (20.7–34.9)
Ejection fraction (%)
Mean ± SD, (range) 30.2 ± 13.8 (11–55)
Hypertension 17 (57%)
Dyslipidemia 10 (33%)
Diabetes 8 (27%)
Smoking 16 (53%)
Positive family history 6 (20%)
Figure 1. Phase analysis of gated SPECT-MPI (A) and PET-
FDG (B) in a patient with severe LV dyssynchrony reveals
comparable results for histogram bandwidth (281 and 280)
and phase SD (79 and 81), respectively.
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remains questionable,3,18 other modalities such as cor-
onary revascularization and resynchronization have
gained importance as valuable treatment option in these
patients. CABG surgery improves survival in patients
with chronic CAD, and the presence of viability has
been considered as one of the most important parameters
of preoperative evaluation. Recently, a poor outcome in
patients undergoing CABG surgery has been associated
with the presence of severe LV dyssynchrony.5,6
Therefore, it has been suggested that both, viability as
well as LV dyssynchrony should be routinely assessed
before CABG surgery.5
CRT is an established therapy for patients with
advanced heart failure. The technique improves heart
failure symptoms, exercise capacity, and LV function,
with a reduction in morbidity and mortality.19,20 How-
ever, 20%-30% of all patients receiving a CRT do not
respond. The search of reasons for nonresponse to CRT
has gained importance in recent investigations. The
presence of LV dyssynchrony as well as the extent of
scar tissue and viable myocardium has been identified as
key parameters directly related to the response to
CRT7-10 suggesting that the evaluation of patient
selection for CRT should include these parameters.
PET-FDG is the only method for viability assess-
ment which has been shown to improve the outcome of
patients when it is used to assist management of severe
LV dysfunction.1 A broad diversity of imaging tech-
niques has been established for LV dyssynchrony
assessment, such as echocardiography, especially with
Figure 2. Correlation of histogram bandwidth (left) and phase SD (right) values between PET-
FDG vs SPECT-MPI (upper panel) and accuracy of PET-FDG to predict LV dyssynchrony (lower
panel). Values greater than 43 (for phase SD) and 135 (for histogram bandwidth) from SPECT-
MPI were considered abnormal (according to Henneman et al17).
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tissue Doppler imaging (TDI) and strain imaging,21,22
magnetic resonance imaging (MRI) and MUGA radio-
nuclide ventriculography. TDI has emerged as one of the
most widely used techniques but may be subject to
interobserver variability in part related to observer
experience.23 MUGA radionuclide ventriculography has
overcome both of the above-mentioned possible disad-
vantages but has not been widely used lately. Recently,
assessment of LV dyssynchrony by phase analysis of
gated SPECT-MPI scans has been established.12 The
evaluation with gated SPECT-MPI scans has potential
benefits, such as the automated and reproducible
assessment and moreover the possibility to gather
information on myocardial perfusion at the same time.
This study now shows that PET-FDG, which is used to
assess viability, allows assessment of the two key
parameters of severe LV dysfunction simultaneously.
This enables comprehensive evaluation of patients
before CABG surgery.
We acknowledge following limitations: first, this is
a single-center study with only a limited population of
30 patients due to the pilot nature of this study. Second,
the use of manual base and apex placement may lead to
bias, especially in a population which typically has a
high prevalence of perfusion defects. However, it has
been described earlier that repeatability of phase anal-
ysis is higher when using manual placement compared
to the automated technique24 justifying the manual
placement tool for phase analysis. In addition, in
patients with large fixed defects, the assessment of LV
dyssynchrony by phase analysis from SPECT-MPI may
be hampered, due to limitations in contour detection. By
contrast, many of these segments had preserved FDG
uptake potentially allowing better contour detection by
PET-FDG scanning. This may have accounted for the
fact that in the upper range of LV dyssynchrony there
appears to be larger variability between the two methods
(see Figure 2).
In conclusion, LV dyssynchrony assessment from
PET-FDG scans is feasible and accurate, compared to
the standard of reference SPECT-MPI, although our data
may not support the interchangeable use of the two
methods in patients with large perfusion defects.
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